Skip to main content
OpenTrials

Clinical trial condition

Leukemia

Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.

4,415 public trials 1,033 recruiting studies
Refine in advanced search Browse all conditions

Leukemia trial results

Recruiting

A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)

NCT06950034

Conditions
Acute Monocytic Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia (AML), +24 more
Locations
  • Stanford University Stanford, California, United States
  • Moffitt Tampa, Florida, United States
  • DFCI Boston, Massachusetts, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details
Recruiting

Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)

NCT04895436

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +14 more
Locations
  • Moores Cancer Center at UC San Diego /ID# 230157 La Jolla, California, United States
  • Winship Cancer Institute of Emory University /ID# 230643 Atlanta, Georgia, United States
  • Des Moines Oncology Research Association /ID# 232606 Des Moines, Iowa, United States
  • Dana-Farber Cancer Institute /ID# 230061 Boston, Massachusetts, United States
View all 58 locations
View Trial Details
Recruiting

A Study of CTD402 in T-ALL/LBL Patients

NCT07070219

Conditions
Acute Lymphocytic Leukemia Refractory, Disease Attributes, Hematologic Diseases, +14 more
Locations
  • Stanford University Palo Alto, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • University of Chicago Chicago, Illinois, United States
  • Mayo Clinic - Rochester Rochester, Minnesota, United States
View Trial Details
Recruiting

Alternating Regimen of VA and Low-dose CHA in the Treatment of Unfit Newly Diagnosed AML

NCT07172204

Conditions
Age ≥60, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
Locations
  • Beijing Chao-Yang Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Shenzhen University General Hospital Shenzhen, Guangdong, China
  • the First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China
  • the Second Affiliated Hospital of Nanchang University Nanchang, Jiangxi, China
View Trial Details
Recruiting

Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)

NCT03666000

Conditions
B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, Chronic Disease, +27 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • City of Hope Duarte, California, United States
  • H. Lee Moffitt Cancer Center Tampa, Florida, United States
  • Winship Cancer Institute Emory University Atlanta, Georgia, United States
View all 23 locations
View Trial Details
Recruiting

Study Comparing the Efficacy of 2 RIC Regimens (Clofarabine vs Fludarabine) in Adults With AML Eligible to Allo-SCT

NCT05917405

Conditions
Acute Myeloid Leukemia in Remission, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • CHU de Nantes Nantes, Loire Atlantique, France
  • CHU Amiens Amiens, France
  • CHU Angers Angers, France
  • CHU Besançon Besançon, France
View all 23 locations
View Trial Details

Related conditions